Overview

Trial of Testosterone Undecanoate for Optimizing Performance During Military Operations

Status:
Completed
Trial end date:
2021-07-08
Target enrollment:
Participant gender:
Summary
The objective of this study is to determine the effects of a single dose of testosterone undecanoate during and in recovery from simulated operational stress.
Phase:
Phase 4
Details
Lead Sponsor:
Pennington Biomedical Research Center
Collaborators:
United States Army Research Institute of Environmental Medicine
United States Department of Defense
University of Arkansas
Treatments:
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate